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The ability to interconvert terminally differentiated
cells could serve as a powerful tool for cell-based
treatment of degenerative diseases, including dia-
betes mellitus. To determine which, if any, adult
tissues are competent to activate an islet b cell pro-
gram, we performed an in vivo screen by expressing
three b cell ‘‘reprogramming factors’’ in a wide spec-
trum of tissues. We report that transient intestinal
expression of these factors—Pdx1, MafA, and Ngn3
(PMN)—promotes rapid conversion of intestinal
crypt cells into endocrine cells, which coalesce into
‘‘neoislets’’ below the crypt base. Neoislet cells ex-
press insulin and show ultrastructural features of b
cells. Importantly, intestinal neoislets are glucose-
responsive and able to ameliorate hyperglycemia
in diabetic mice. Moreover, PMN expression in hu-
man intestinal ‘‘organoids’’ stimulates the conver-
sion of intestinal epithelial cells into b-like cells.
Our results thus demonstrate that the intestine is
an accessible and abundant source of functional
insulin-producing cells.
INTRODUCTION
Type 1 and type 2 diabetes are associated with either destruc-
tion or dysfunction of pancreatic b cells. The ability of cadav-
eric islet transplantation to restore euglycemia in patients with
severe type 1 diabetes—the ‘‘Edmonton protocol’’—has fueled1046 Cell Reports 6, 1046–1058, March 27, 2014 ª2014 The Authorsefforts to create a reproducible and immune-compatible source
for new b cells (Shapiro et al., 2000). Such efforts, particularly
those utilizing human embryonic stem cells (ESCs) or induced
pluripotent cells (iPSCs), have made some headway (Cheng
et al., 2012; Jiang et al., 2007; Kroon et al., 2008). Nevertheless,
there have been conflicting reports, and a number of significant
technical issues remain (D’Amour et al., 2006; Kroon et al.,
2008).
The discovery that ectopic expression of four transcription
factors can reprogram a terminally differentiated cell to plurip-
otency has reinvigorated the field of somatic cell transdiffer-
entiation (Takahashi and Yamanaka, 2006). In the pancreas,
adenovirus-mediated introduction of three transcription fac-
tors involved in normal islet development—Pdx1 (P), MafA
(M), and Ngn3 (N)—can induce acinar cells to become insu-
lin-producing cells in an immune-deficient mouse (Zhou
et al., 2008), raising the prospect of using differentiated
pancreatic cells as a source for new b cells. These findings
have been partially reproduced in cultured cells, although the
cells that arise following ‘‘reprogramming’’ in vitro lack many
of the features of functional b cells (Akinci et al., 2012; Hickey
et al., 2013).
Given recent studies indicating that adult cells retain a high
degree of cellular plasticity (Ieda et al., 2010; Kajimura et al.,
2009; Takahashi and Yamanaka, 2006; Vierbuchen et al.,
2010; Xie et al., 2004; Yanger et al., 2013; Zhou et al., 2008),
we reasoned that misexpression of the PMN transcription fac-
tors in a wide variety of tissues might permit identification of
other cell types that can undergo conversion to a b or b-like
state in vivo. In the current study, we ectopically expressed
the PMN factors in an immune-competent mouse to screen
for such tissues.
Figure 1. An In Vivo Screen for Tissues Competent to Initiate Insulin Transcription
(A) Schematic representation of transgenes used to generate Dox-inducible Tetß mice. A cassette containing Pdx1,MafA,Ngn3, and H2B-GFP cDNAs linked by
2A peptide sequences (T2A, P2A) under the tetracycline-responsive promoter (TRE-tight) was targeted into the Rosa26 locus, resulting in the R26Tetß-targeting
construct.
(B) Schematic showing breeding of R26Tetß and R26rtTA*M2 mice to generate double-transgenic (DTG) mice. Mice bearing either the R26Tetß or R26rtTA*M2
transgene served as controls.
(C–H) GFP induction in DTG tissues after 4 days of Dox treatment. Immunofluorescence images showing GFP and costaining with the indicated markers. GFP
was detected by direct epifluorescence. Note the absence of GFP in the liver (C) and pancreatic islets (D). Coexpression of GFP and Pdx1 is shown in pancreatic
acinar cells (D), intestinal epithelial cells (E), and spleen cells (H). The scale bars represent 25 mm.
See also Figure S1.RESULTS
Widespread Expression of PMN Factors In Vivo
We combined a 2A self-cleaving peptide-based strategy
(Szymczak et al., 2004) with an inducible doxycycline-dependent
expression (Tet-On) system to investigate the effect of ectopic
PMN expression in vivo. Initially, the PMN factors and an H2B-
Cherry reporter were connected by 2A peptide sequences and
cloned in-frame into the FUW lentiviral backbone to generate
pLenti-Beta (Figure S1A, top). Expression of all three proteins,
as well as the H2B-mCherry reporter, was confirmed in 293T
cells and a human hepatocyte cell line (Figures S1A and S1B).
We then generated R26Tetß ESCs by replacing H2B-Cherry se-
quences with an H2B-GFP reporter, cloning the PMN-GFP open
reading frame downstream of a tetracycline response element
(TREtight) and targeting the resulting Tetß cassette to the
Rosa26 locus of mouse ESCs. Next, we generated R26Tetß
mice and crossed them to R26-rtTA*M2 mice (Hochedlinger
et al., 2005), permitting widespread doxycycline (Dox)-regulated
expression of the PMN factors and the GFP reporter in double
transgenic (DTG) animals (Figure 1B). Without Dox treatment,
there was no GFP (Figure S1C). Following 3 days of Dox treat-
ment, GFP and PMN factors were detected in the pancreas, in-
testine, gallbladder, skin, spleen, and bonemarrow, but not liver,Celung, heart, or kidney (Figures 1C–1H and S1E; data not shown).
Within the pancreas, expression was observed in the exocrine
compartment, but not in islets (Figures 1D and S1E).
Robust Induction of Insulin-Secreting Cells in the
Intestine
DTGmicewere analyzed for effects on glucose homeostasis and
insulin production. After 3 to 4 days of Dox administration, DTG
animals exhibited a profound decrease in blood glucose (BG)
levels in the fed state (Figure 2A) and overt symptoms of hypogly-
cemia, including lethargy, seizure, and coma. To determine
whether hypoglycemia might be due to ectopic insulin produc-
tion, we examinedRNA froma variety of DTGmouse tissues after
3 days of Dox (D3 DTG) for insulin transcripts. Surprisingly, we
found transcripts for Ins1 and Ins2 in the duodenum, jejunum,
and ileum in addition to tissues in which insulin is normally tran-
scribed—pancreas, thymus, andbrain (Figure 2B).We confirmed
ectopic insulin production at the protein level by ELISA, which re-
vealed significantly elevated levels in theduodenumand jejunum,
but not in other parts of the intestineor in other tissues (Figure 2C).
Notably, there was no increase in pancreatic insulin content
at this time point, and staining failed to detect acinar cells that
expressed either the endocrine marker ChromograninA (ChroA)
or insulin itself. Specifically, we examined1,360GFP+ acinar cellsll Reports 6, 1046–1058, March 27, 2014 ª2014 The Authors 1047
Figure 2. Systemic Effects of Intestinal Insulin following PMN Expression
(A) Blood glucose levels of DTG mice following 3 to 4 days Dox treatment (measured after 1 hr fast). ***p < 0.001, Student’s t test.
(B) RT-PCR analysis in multiple tissues from DTG mice and controls treated with 3 days Dox. GAPDH served as a control for template cDNA. BM, bone marrow;
Br, brain; Duo, duodenum; He, heart; Ile, ileum; Jej, jejunum; Kd, kidney; Li, liver; Lu, lung; Pan, pancreas; Sk, skin; Sp, spleen; Thy, thymus.
(C) Measurement of insulin protein in various tissues by ELISA. *p < 0.05, Student’s t test.
(D) Top: Schematic for induction of PMN factors for 3 days with Dox and then ‘‘deinduction’’ for 5 days following Dox removal. Lower left: D3+5d animals have
normal fasting blood glucose (17 hr fast). Lower right: D3+5d animals have improved glucose homeostasis following intraperitoneal glucose challenge. **p < 0.01,
Student’s t test.
(E) RT-PCR analysis of insulin (Ins1 and Ins2), Pdx1, MafA, and Ngn3 transcript abundance in multiple tissues from D3+5d deinduced mice.
See also Figure S2.(out of a total of 5,818 acinar cells counted; n = 2), and none
costained for insulin (Figure S1D; data not shown). These results
suggest that hypoglycemia in Dox-treated DTG animals results
from intestinally derived insulin production.
We then developed a protocol whereby animals were treated
with Dox for 3 days and then ‘‘deinduced’’ by removing Dox
for 5 days prior to analysis (D3+5d; Figure 2D). Under these con-
ditions, BG levels dropped transiently during Dox treatment and
then rose following Dox withdrawal (Figure S2A), resulting in a
normal fasting BG in D3+5d DTG animals (Figure 2D). Despite
this, such animals still exhibited an improved response to
glucose challenge compared to control littermates (Figure 2D).
Transcripts for Ins2 (but not Ins1) persisted in the intestines
of D3+5d animals, as did transcripts for Pdx1, MafA, and Ngn31048 Cell Reports 6, 1046–1058, March 27, 2014 ª2014 The Authors(Figure 2E). Consistent with our earlier immunofluorescence (IF)
experiments showing a lack of acinar insulin staining, there
was no increase in total pancreatic insulin content in D3+5d
animals (Figure S2B). Notably, deinduced DTGanimals exhibited
a trend toward early and enhanced insulin release into the
blood following glucose challenge (Figure S2C). Thus, intestinal
expression of Pdx1, MafA, and Ngn3 drives the formation
of ectopic insulin-producing cells that confer an improved
response to glucose challenge without fasting hypoglycemia.
Intestinal Insulin+ Cells Are Epithelially Derived and
Form ‘‘Neoislets’’
In contrast to control intestines, in which rare ChroA+ enteroen-
docrine cells were scattered in the differentiated regions of the
Figure 3. Intestinal Insulin+ Cells Are Epithe-
lially Derived and Form Neoislets
(A and B) Representative immunofluorescence im-
ages of D3+5d DTG intestines stained for ChroA (A)
and insulin (B). H2B-GFP marks ‘‘label-retaining’’
(nondividing) cells in the intestine in deinduced
D3+5d mice.
(C) Representative sections of D3 and D3+5d mice
intestine stained for insulin (Ins), E-cadherin (Ecad),
and DAPI.
The scale bars represent 25 mm. See also Figure S3.intestinal villi, ChroA+ cells were abundant in the undifferenti-
ated crypt regions of D3 DTG intestines, where most cells
were also positive for GFP (data not shown). Following deinduc-
tion (D3+5d), there were fewer ChroA+/GFP+ cells, and those
that remained persisted as islet-like clusters lying near or
below the crypt bases (Figure 3A). 5-ethynyl-20-deoxyuridine
and phosphohistone 3 staining suggested that these cells
were nonproliferative (Figure S3A; data not shown). Thus,
H2B-GFP retention served as a marker for cells that had previ-
ously expressed the PMN factors. We refer to these clusters as
neoislets.
We then stained D3 and D3+5d DTG intestines for various
pancreatic hormones. As expected, IF for insulin showed
no staining in the intestines of control animals (Figure 3B). By
contrast, we saw abundant insulin+ cells within the intestines of
D3 DTG animals. Insulin+ cells were concentrated in crypts,
with some scattered cells in villi (Figure 3C; data not shown).
Although this insulin staining never overlappedwith somatostatin
staining (data not shown), a small fraction ofGFP+ cells inD3DTG
mice were either glucagon+ (71 out of 3,368 GFP+ cells; 2.1%) orCell Reports 6, 1046–105glucagon+ /insulin+ (98 out of 3,368 GFP+
cells; 2.9%). Insulin+ cells made up 35.7%
of the GFP+ cells at this stage (1,201 out
of 3,368 GFP+ cells). After 5 days of dein-
duction (D3+5d), most insulin+ cells were
present within the neoislet GFP+ clusters,
where they comprised 31.6% of the GFP+
cells (197 out of 623 GFP+ cells; n = 2;
Figures 3B and 3C). Interestingly, no
glucagon+ cellswere detected in the neois-
lets of D3+5d mice (Figure S3B). Confocal
microscopy demonstrated that the epithe-
lial marker E-cadherin (Ecad) was present
on the membranes of intestinal GFP+/
insulin+ cells in both D3 and D3+5d mice
(Figure 3C).
Intestinal Insulin+ Cells Exhibit
Features of Functional b Cells
We next sought to determine the extent to
which the insulin+ cells in DTG intestines
resembled normal islet b cells. We began
by quantifying the expression of several
b-cell-enhanced genes in crypt prepara-
tions taken from DTG or control animals.Transcripts for several genes—including the kir6.2 and Sur1
subunits of the pancreatic b cell KATP channel, glucose trans-
porter Glut2 glucokinase (GCK), and Ins2 itself—were induced
in DTG crypts in both the acute and deinduced state, although
transcript abundance was dramatically lower compared to
purified islets (Figures 4A and S4B). Moreover, quantification of
transcript levels for Nkx2.2 and Nkx6.1—two transcription fac-
tors important for b cell identity and function—revealed that
Nkx2.2, but not Nkx6.1, was increased (Figure S4A). Earlier
report suggested that depletion of FoxO1 induces insulin
expression in gut cells (Talchai et al., 2012). We therefore
measured the FoxO1 transcript levels in GFP+ crypt cells
but observed no difference between DTG and control cells
(Figure S4C). Interestingly, we found two CpG sites (182
and 171) within the Ins2 promoter that were less methylated
in sorted GFP+ DTG crypt cells compared to control cells (Fig-
ure S4D). Notably, the relative decrease in Ins2 methylation
(30%; Figure S4D) correlated well with the percentage of
GFP+ cells that were copositive for insulin in these samples
(also 30%), suggesting that promoter demethylation is a8, March 27, 2014 ª2014 The Authors 1049
Figure 4. Physiological Features of Intestinal Insulin+ Cells
(A) Quantitative PCR analysis of the b cell transcripts Kir6.2, Sur1,Glut2, and glucokinase (GCK) in normal islets and crypts from control or DTG mice. Crypt cells
were isolated from 20 cm segments of mouse small intestines as described in Experimental Procedures. ***p < 0.001, Student’s t test.
(B) Electronmicrographs of a pancreatic b cell from a control mouse and an intestinal crypt cell fromD3+5dDTGmouse. b-granules (yellow arrows) can be seen in
both. Nuc, nucleus.
(C) Glucose-stimulated insulin secretion from intestinal crypt cells. Crypts were isolated from control or DTG intestines as indicated. Insulin was measured by
ELISA in the presence of 3 mM or 15 mM glucose for 20 min. The red dashed line (0.2 ng) reflects the background level of the assay (buffer alone). p = 0.0286 by
one-way ANOVA between three groups (control, DTG 3 mM glucose, and DTG 15 mM glucose). *p < 0.05.
(D) Blood glucose levels of control and DTG animals treated with streptozotocin (STZ) and Dox. Four days after STZ injection, mice were given Dox for 3 days. On
day 12 (5 days after Dox withdrawal), mice were subjected to glucose-tolerance testing (GTT). *p < 0.05, **p < 0.01, ***p < 0.001, Student’s t test.
(E) Blood-glucose levels of control and DTG mice treated with STZ and Dox and challenged with an intraperitoneal injection of glucose (GTT) at day 12 (see D).
(F) Kaplan-Meier analysis of control and DTG mice treated with STZ. p < 0.001 between groups.
Data are presented as mean ± SD in (A) and mean ± SEM in (C)–(F). The scale bars represent 1 mm. See also Figure S4.rate-limiting step for insulin expression. In islet b cells, insulin is
processed and stored in secretory granules that appear ultra-
structurally as an electron-dense core surrounded by a clear
halo. These dense-core secretory granules are critical for insulin
secretion in b cells in response to glucose stimulation. Using
electron microscopy, we found intestinal crypt cells from
D3+5d DTGmice that contained this hallmark of b cell ultrastruc-
ture, whereas such granules could not be found in control crypt
cells (Figure 4B).1050 Cell Reports 6, 1046–1058, March 27, 2014 ª2014 The AuthorsAs the neoislet cells were ‘‘mono’’ hormonal and equipped
with glucose-sensing and insulin-releasing machinery (Figures
3, 4A, and 4B), we sought to determine whether these insulin+
intestinal cells exhibit glucose-responsiveness. Normal mouse
islets do not secrete insulin when exposed to 3 mM glucose,
whereas half-maximal stimulation is achieved at 11 mM
glucose (Hedeskov, 1980). Hence, we exposed crypts from
control, D3, or D3+5d animals to 3 mM or 15 mM glucose
and measured insulin release. Whereas control crypts had a
background signal that did not differ between low and high
glucose, crypts from DTG mice (D3 and D3+5d) exhibited a sig-
nificant increase in insulin secretion in 15 mMglucose compared
to 3 mM glucose (Figure 4C). These findings suggest that the
crypt cells from DTG mice secrete insulin in a glucose-sensitive
manner.
Next, we determined whether the intestinally derived insulin+
cells could function in place of islet b cells to maintain glucose
homeostasis. To this end, we rendered mice diabetic with the
b cell toxin streptozotocin (STZ) and tested the effects of PMN
induction on survival and glucose homeostasis. Four days after
injection of a single dose of STZ, all animals exhibited a marked
elevation in nonfasting BG (450–500 mg/dl as compared to
150 mg/dl before treatment). Dox was then administered for
3 days to induce the PMN factors. In Dox-treated DTG mice,
BG levels returned to normal (mean 134 mg/dl; Figure 4D), a
recovery that was associated with normalized serum insulin
levels (Figure S4E). In contrast, BG of Dox-treated control mice
remained high (>500 mg/dl) for the duration of the experiment
(Figure 4D).
Although BG levels in DTG mice began to rise following dein-
duction (Figure 4D), STZ-treated DTG animals on day 12 ex-
hibited a markedly better response to glucose challenge than
controls (Figures 4D and 4E). This improvement was associated
with better survival for animals with STZ-induced diabetes, with
100% of DTG animals surviving 2 weeks after deinduction
as compared to only 40% of control animals (Figure 4F). The
improved glucose homeostasis in diabetic DTG mice at this
time point was not due to pancreatic b cell regeneration, as islet
b cells were barely detectable in either control or DTG animals
2 weeks after STZ treatment whereas insulin+ neoislets were still
present at this stage (data not shown). These results indicate that
functional insulin-producing glucose-responsive cells persist in
the intestine after exogenous PMN expression has ceased.
Intestinal Insulin+ Cells Originate from Crypt Cells and
Ngn3+ Cells
To determine whether neoislets were derived from intestinal
epithelial cells, we generated a panel of transgenic mouse lines
that express rtTA*M2 under control of the Villin promoter (Villin-
rtTA*M2), a well-characterized promoter element that directs
broad expression within the intestinal epithelium (el Marjou
et al., 2004; Madison et al., 2002; Pinto et al., 1999). Using a
DNA construct in which a 13 kb regulatory region of mouse Villin
was placed upstream of rtTA*M2 coding sequences, we created
five transgenicVillin-rtTA*M2 founder lines.When crossed toTet-
H2BGFP reporter mice (Tumbar et al., 2004), two of these lines—
V3andV5—yielded distinct epithelial patterns ofGFP expression
in thepresenceofDox (Figure 5A). Specifically,GFPfluorescence
wasobserved throughout the crypt-villus axis in V5TetGFP (Villin-
rtTA*M2V5; Tet-H2BGFP) mice but was limited to the villi of
V3TetGFP (Villin-rtTA*M2V3; Tet-H2BGFP) mice (Figures 5B
and 5C). We reasoned that these unique patterns of transgene
activity might permit us to determine whether the intestinal
insulin+ cells are derived from the crypt compartment.
Villin-rtTA*M2 (V3 or V5) mice were bred to R26Tetßmice, and
the resulting V3DTG and V5DTG mice were treated with Dox for
3 days. Immunofluorescence for insulin revealed that V5DTG,Cebut not V3DTG or control mice, harbored intestinal insulin+ cells
(Figure 5E). Consistent with these results, V5DTG mice had an
improved response to glucose challenge whereas V3DTG mice
responded normally (Figures 5F and 5G). These results suggest
that the ectopic insulin+ cells are derived from epithelial precur-
sors that reside in the intestinal crypts.
We hypothesized that some of these insulin+ crypt cells might
originate from enteroendocrine progenitor cells that express the
basic helix-loop-helix proteinNgn3 (Jenny et al., 2002; Johansson
et al., 2007; Schonhoff et al., 2004; Wang et al., 2009). To test
this hypothesis, we employed a lineage-tracing strategy to mark
endocrine progenitor cells and determined whether they give
rise to intestinal insulin+ cells. We crossed Ngn3CreER mice,
whichcarrya tamoxifen (TM)-inducibleCre recombinasegeneun-
der thecontrol of theNgn3promoter (Guet al., 2002) toR26Cherry
mice, which carry a lox-STOP-lox cassette upstream of an H2B-
mCherry reporter gene, resulting in bigenic NCmice (Figure S5A).
As expected from previous reports (Jenny et al., 2002; Schonhoff
et al., 2004), Cherry-labeled cells were observed in crypts and
scattered villi following two injections of TM (Figure S5B).
We then introduced the NC alleles into the V5DTG background
to generate Ngn3CreER, R26Cherry, V5-rtTA, and R26Tetb
(NCVB) mice. NCVB mice were given two injections of TM to
label Ngn3+ endocrine progenitors, treated with Dox for 4 days
to induce intestinal expression of the PMN factors, and then
examined 3 days later for expression of GFP, mCherry, and insu-
lin (Figure 6). A total of 6,697 crypt cells were counted, of which
790 stained for GFP and 64 stained for mCherry (Figure 6C).
Consistent with our prior measurements, 29.1% of the GFP+
cells costained for insulin. Notably, 8.7% of these GFP+/Ins+
cells were also positive for mCherry, indicating they had origi-
nated from Ngn3+ cells. We then examined the mCherry+ cells
and found that two-thirds of them (41/64) were GFP+, indicating
efficient expression of the Tetb transgenewithin this pool of cells.
Significantly, 20 out of these 41 GFP+/mCherry+ cells also
expressed insulin (Figure 6C), indicating that PMN expression
in an Ngn3-marked cell is associated with a nearly 50% chance
of the cell becoming insulin+. Taken together, these data suggest
that at least some of the intestinal insulin+ cells observed in Tetb
mice are progeny of Ngn3+ endocrine progenitor cells. However,
because Ngn3CreER does not result in labeling of all endocrine
progenitors, we cannot conclude whether all or only a fraction of
the intestinal insulin+ cells came from this source.
Generating Insulin+ Cells from Human Intestinal
Organoids
We next sought to determine whether human intestinal cells are
capable of acquiring b-like characteristics under the influence of
PMN. To this end, we used human ESC (hESC)-derived intestinal
organoids to generate three-dimensional structures containing
Lgr5+/Ascl2+ crypt-like domains in vitro (McCracken et al.,
2011). Importantly, these structures recapitulate many of the
features of normal human intestinal tissue, including an intact
crypt-villus axis and differentiation of all intestinal lineages
(Spence et al., 2011).
Infection of human intestinal organoids (HIOs) with either lenti-
beta or lenti-H2BCherry viruses resulted in the appearance
of H2BCherry+ cells with an efficiency ranging from 4% to 13%ll Reports 6, 1046–1058, March 27, 2014 ª2014 The Authors 1051
Figure 5. Intestinal Insulin+ Cells Are Derived from Crypts
(A) Schematic of Villin-rtTA transgene experiments.Different founder ofVillin-rtTAmouse lineswere bredwith Tet-GFPmice to obtain V3TetGFPor V5TetGFPmice.
(B) The V3-rtTA transgene drives GFP expression in villi, but not crypts, after Dox treatment.
(C) The V5-rtTA transgene drives GFP expression throughout the crypt-villus axis after Dox treatment.
(D) Schematic of experimental design. V3 and V5-rtTA mouse lines were bred to R26Tetß mice to generate V3DTG and V5DTG mice, respectively. V3DTG,
V5DTG, and littermate control mice were given Dox for 3 days and then fasted for 17 hr prior to intraperitoneal (i.p.)-GTT assay. Intestinal tissues were collected
after i.p.-GTT experiments.
(legend continued on next page)
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Figure 6. Intestinal Insulin+ Cells Can Arise from Ngn3+ Cells
(A) Schematic of Ngn3-lineage-tracing experiment in insulin+ crypt cells. V5DTG mice were bred to Ngn3CreER and R26Cherry reporter mice to generate NCVB
mice. Four- to five-week-old NCVB mice were injected twice with 8 mg tamoxifen (TM) to label the Ngn3+ cells. Mice were then given Dox-containing water for
4 days to induce intestinal PMN expression followed by 3 days of untreated water prior to analysis.
(B) Representative IF images of NCVB intestines stained for insulin and DAPI. The asterisk indicates a GFP+/insulin+ cell that carries the mCherry Ngn3 lineage
label, whereas arrowheads indicate GFP+/insulin+ cells that are negative for mCherry. The scale bars represent 10 mm.
(C) Quantification of Ngn3-lineage-traced insulin+ crypt cells.
See also Figure S5.(Figure 7A). Analysis of RNA from infected HIOs revealed a dra-
matic increase of transgene (Pdx-1, Ngn3, and MafA) as well as
human INS transcripts in lenti-beta-infected HIOs as compared
to lenti-H2BCherry-infected HIOs, with no change in transcript
levels for CDX2, VILLIN, and MUC2 (Figure 5B). Confocal IF for
H2BCherry, insulin, and C-peptide confirmed that lenti-beta-in-
fected cells, but not Lenti-H2BCherry-infected cells, expressed
insulin as well as C-peptide (Figure 7C). Specifically, approxi-
mately 22% of the lenti-beta-infected cells stained for human(E) Representative IF images of VDTG intestines stained for insulin and DAPI. As
(F and G) Results of i.p.-GTT testing. V5DTG, but not V3DTG, show significant clea
*p < 0.05, **p < 0.01, ***p < 0.001, Student’s t test.
The scale bars represent 25 mm (B and C) and 20 mm (E).
CeC-peptide, whereas none of the lenti-H2BCherry-infected cells
did (Figure 5C).
To achieve uniform temporal and reversible control of PMN
genes expression in hESC-derived HIOs, we generated the
pInducer-GFP and pInducer-beta viruses from an inducible
lenti-vector system (Meerbrey et al., 2011; Figure S6A). Human
ESCs were infected with either pInducer-beta or pInducer-GFP
virus, and neomycin selection was applied to establish stable
cell lines, which in turn were used to generate Inducer-beta orterisks depict insulin+/GFP+ cells in V5DTG mice.
rance of glucose compared to their control littermates. Data are means ± SEM.
ll Reports 6, 1046–1058, March 27, 2014 ª2014 The Authors 1053
Figure 7. Insulin Production in Human Crypt Cells following PMN Expression
(A) Whole-mount bright field and immunofluorescence images from human intestinal crypt organoids (HIOs) infected with lenti-H2BCherry or lenti-beta virus.
Infection rates were calculated by counting H2B-Cherry+ cells as a percentage of epithelial cells in the organoids.
(B) Quantitative PCR analysis of HIOs after infection with lenti-H2BCherry or lenti-beta virus for the indicated transcripts compared to GAPDH control. Exper-
iments were performed using biological triplicates (each biological group contained at least five organoids). *p < 0.05, Student’s t test.
(C) Immunofluorescence for H2BCherry, insulin, and C-peptide in lenti-H2BCherry- or lenti-beta-infected organoids. Insulin+/C-peptide+ cells were detected
exclusively in lenti-beta-infected human crypt organoids and quantified (right). *p < 0.05, Student’s t test.
(D) Immunofluorescence for insulin and C-peptide in inducible HIOs. Inducible HIOs were generated from Inducer-GFP or Inducer-beta-virus-infected hESCs.
Insulin and C-peptide signals were detected and colocalized with GFP+ cells in Inducer-beta HIOs.
(E) Quantitative PCR analysis of inducible HIOs for the indicated transcripts compared toGAPDH control. Experiments were performed using biological triplicates
(each biological group containing at least five organoids). *p < 0.05, **p < 0.01, Student’s t test. Data are presented as mean ± SEM.
The scale bar represents 10 mm (C) and 50 mm (D). See also Figure S6.Inducer-GFP HIOs. After 1 month of organoid formation, the
transgenes were induced by 10 days treatment with Dox fol-
lowed by IF and RNA analysis. Following this treatment, GFP+
clusters were readily seen in Inducer-beta HIOs, similar in
appearance to the neoislets we observed in DTG mice in vivo
(Figure S6B). IF analysis demonstrated robust expression of
Pdx-1, Ngn3, and ChroA in the GFP+ cells (Figures S6C and
S6D); moreover, insulin and C-peptide staining was present in
a large fraction of the cells (Figures 7D, S6C, and S6D). RNA
analysis revealed significant induction of human INS and SUR1
transcripts, but no increase in KIR6.2 or NKX6.1. These results1054 Cell Reports 6, 1046–1058, March 27, 2014 ª2014 The Authorssuggest that, within human organoids—an in vitro environment
that recapitulates features of the normal human intestine—
PMN expression enables a b-like conversion similar to the one
observed in the DTG mouse model.
DISCUSSION
Generating Insulin+ Cells in the Intestine
We have conducted an in vivo screen for adult cell types that are
competent to become insulin-producing cells. We found that
ectopic expression of Pdx1, MafA, and Ngn3 in the intestinal
crypts, but not villi, results in their conversion into cells with b-like
features. These include the production and processing of insulin,
formation of cytoplasmic b-granules, and expression of com-
ponents of the glucose-sensing machinery. Importantly, these
insulin+ crypt cells can sense glucose levels and release insulin
in response to high glucose, a property that can ameliorate the
hyperglycemia caused by STZ-induced b cell ablation in vivo.
Finally, these changes in cell phenotype are reproduced in hu-
man intestinal organoids, suggesting that the human intestine
may also be competent to give rise to functional insulin-produc-
ing cells.
Adenoviral delivery of one or more PMN factors in either hepa-
tocytes (Ferber et al., 2000; Kaneto et al., 2005; Yechoor et al.,
2009) or pancreatic acinar cells (Zhou et al., 2008) can promote
the formation of insulin+ cells in vivo. DTG mice failed to express
the PMN factors in the liver, and thus the R26Tetß system could
not be used to assess the competence of hepatic cells to
become insulin+ cells with these three genes. This lack of hepatic
expression was not due to a failure of the Tet-On system,
because GFP was readily detectable in the liver of Dox-treated
R26-rtTA*M2; Tet-GFP mouse (Figure S1D). This suggests that
other factors or negative regulators in the liver are responsible
for silencing of the PMN polycistronic mRNA.
By contrast, we observed robust expression of the PMN fac-
tors in the exocrine pancreas. Despite this, we were unable to
detect insulin or ChroA staining in the acinar cells of DTG mice.
There are several potential explanations for the discrepancy be-
tween our results and previous studies reporting ‘‘acinar reprog-
ramming’’ (Akinci et al., 2012, 2013; Zhou et al., 2008). First, the
adenoviral deliverymethod employed by these studiesmay have
established an inflammatory microenvironment that was more
conducive to cellular transdifferentiation, as has been suggested
(Lee et al., 2012; Wang et al., 2007). Alternatively, the in vivo con-
version of acinar cells to b-like cells (Zhou et al., 2008) may have
required a specific stoichiometry of PMN expression that was
not achieved in the Tetß system. Such a dependence on stoichi-
ometry has been noted in studies using polycistronic vectors
to create iPSCs (Carey et al., 2011). Despite this difference in
cellular competence, the morphogenetic and transcriptional
changes that we observed in the intestine occur with a rapidity
that echoes the observations of Zhou et al. After only 3 days of
PMN expression, GFP+/insulin+ cells were abundant in intestinal
crypts and villi. Five days later (after deinduction), these cells had
coalesced as neoislets. Moreover, whereas a subset of GFP+
cells coexpressed glucagon during the induction period, insulin
was the only hormone detected in neoislets.
Origins of Intestinal Insulin+ Cells
Which cells within the intestinal epithelium give rise to neoislets?
We have shown that neoislets emerge principally from the duo-
denum and proximal jejunum, sections of the midgut that are
in close apposition to prepancreatic endoderm during develop-
ment. Hence, we speculate that this portion of the intestine
retains competence to give rise to b-like cells by virtue of its
embryonic heritage.
Using an allelic series of Villin-rtTA driver strains, we demon-
strated that neoislets are derived from the intestinal crypts rather
than villi. Furthermore, using a combination of rtTA-mediatedCemisexpression and Cre-mediated lineage tracing, we found
that at least some of the neoislet cells are derived from endocrine
progenitor cells. Others (Cheung et al., 2000) have previously
shown that mouse intestinal K cells are capable of correctly pro-
cessing human insulin. Although our lineage-tracing studies
cannot exclude the possibility that some of the insulin+ cells
are derived from differentiated cells, such as K cells, our results
are more reminiscent of the findings of Talchai and colleagues
(Talchai et al., 2012), who reported that deletion of FoxO1 in
gut Ngn3+ cells resulted in the emergence of intestinal insulin+
cells. Importantly, there was no difference in FoxO1 expression
when we compared DTG and control crypt cells (Figure S4C),
suggesting that FoxO1 lies upstream of the PMN factors or
that the two genetic manipulations promote the formation of
insulin+ cells by independent mechanisms. Given that Ngn3 pro-
genitors comprise only1% to 2%of cells within the crypts, and
neoislets emerge rapidly and robustly in the absence of signifi-
cant cell division (Figure S3), it remains possible or even likely
that other cell types in addition to Ngn3+ progenitors contribute
to neoislet formation.
Functionality of Intestinal Insulin+ Cells
Although the neoislets in DTG intestines are unlikely to contain
fully functional b cells, several lines of evidence suggest that
these cells have ‘‘b-like’’ properties that could prove useful. First,
neoislet cells are monohormonal and have morphological and
molecular hallmarks of b cells, including the ability to process
preproinsulin into its mature form (with release of C-peptide), up-
regulation of the genes encoding the b cell KATP channel subunits
Kir6.2 and Sur1, and the presence of distinctive b-granules.
Furthermore, D3+5d animals have improved glucose tolerance
with no decrease in fasting blood glucose, suggesting that the
neoislets function in a regulated fashion. Neoislets conferred a
marked survival benefit in diabetic animals, and even several
days after transient expression of the PMN factors had ceased,
STZ-treated diabetic DTG animals retained a better response to
glucose challenge than nontransgenic animals. Finally, crypts
isolated from D3 or D3+5d Dox-treated animals secreted insulin
in response to high, but not low, concentrations of glucose.
Nevertheless, neoislet cells gradually disappear from DTG in-
testines after deinduction (2 to 3 weeks). One possible expla-
nation is that ectopic PMN factors are not sufficient to establish
a stable b-like state, a status that might require additional coop-
erating transcription factors. One attractive candidate for such a
‘‘missing’’ factor is Nkx6.1, as this b-cell-enriched transcriptional
regulator was not induced by PMN in vitro or in vivo. Nkx6.1 is
essential for the establishment of b cell identity during develop-
ment (Schaffer et al., 2013) and appears to be necessary for b
cell maturation (Rezania et al., 2013; Taylor et al., 2013), a role
that is compatible with the immature phenotype we observe
in DTG neoislets. These issues of stability and functionality will
need to be addressed before neoislets can be considered for
diabetes therapy.
Full-fledged cellular reprogramming, as occurs in the conver-
sion of differentiated fibroblasts to a pluripotent state, requires
the formation of stable feedforward transcriptional networks, a
process that involves marked chromatin remodeling (Apostolou
and Hochedlinger, 2013; Buganim et al., 2013). Our organoidll Reports 6, 1046–1058, March 27, 2014 ª2014 The Authors 1055
experiments suggest that the expression of exogenous PMN
factors (mouse origin) does not result in the induction of their
endogenous (human) counterparts (PDX-1 and NGN3). Because
the intestinal insulin+ cells have not achieved such a transcrip-
tional rewiring, we do not believe they represent fully ‘‘reprog-
rammed’’ b cells. Nevertheless, we propose that the PMN
factors do cause a ‘‘partial’’ reprogramming, as our finding of
decreased Ins2 promoter methylation represents evidence for
epigenetic rewiring of the cells. Our studies thus create a frame-
work for the identification of additional factors that can promote
‘‘complete’’ reprogramming of fully functional b cells from the
intestinal epithelium.
Over the past decade, there has been major interest in iden-
tifying cell populations that can be coaxed into becoming
pancreatic b cells. Our results provide strong evidence that the
intestine, one of the largest tissues of the body, is an appealing
candidate. Moreover, our findings with human intestinal organo-
ids suggest that the human intestinal cells might preserve the
ability to form b-cell-like neoislets. Given the almost unlimited
potential for expansion of human intestinal tissue in culture
(Sato et al., 2011), our observation that ectopic expression of
PMN causes human intestinal organoids to adopt b-like features
suggests that it may be possible to exploit and extend these find-
ings in humans, potentially for therapy.
EXPERIMENTAL PROCEDURES
Mouse Strains
The following mouse strains were utilized in this study: R26Tetß, Villin-rtTA (V3
and V5), R26rtTA*M2 (Hochedlinger et al., 2005), Tet-H2BGFP reporter mice
(Tumbar et al., 2004), and Ngn3CreERTM (Gu et al., 2002). R26rtTA*M2 and
TetGFP reporter mice were obtained from Jackson Lab. R26Cherry mice
were made by targeting a CAGS-lox-PGK-neo-p(A)-lox-H2BCherry p(A)
cassette into ROSA26 locus in V6.5 ESCs (kindly provided by Dr. Doug
Melton). Methods for making the R26Tetß and Villin-rtTA mouse strains are
detailed in the Supplemental Experimental Procedures. Both male and female
mice at 4–6 weeks of age were used for all experiments; post hoc analysis
revealed no gender effect on the experimental results. To induce PMN gene
expression, DTG and V3DTG or V5DTG mice were fed 0.2 mg/ml or 2 mg/ml
doxycycline (Dox; Sigma), respectively, in the drinking water supplemented
with 20 mg/ml sucrose. Tamoxifen (Sigma) was dissolved in corn oil at
40 mg/ml. Four- to five-week-old NCVB mice were given 8 mg tamoxifen on
consecutive days prior to treatment with 2 mg/ml Dox. All animal experiments
were performed in accordance with the National Institutes of Health policies on
the use of laboratory animals and approved by the Institutional Animal Care
and Use Committee of the University of Pennsylvania.
Antibodies and Immunohistochemistry
Tissues were fixed in 4% paraformaldehyde overnight at 4C. Subsequently,
tissues were washed three times in PBS, incubated in 15% sucrose solution
for 23 hr and then 30% sucrose overnight (1216 hr) before optimum cutting
temperature embedding for cryosection. A detailed description of primary an-
tibodies used in IF staining and western blot analysis is provided in the Supple-
mental Experimental Procedures (Table S2). Rhodamine-Red-X-conjugated
and Alexa Fluor-conjugated donkey secondary antibodies were obtained
from the Jackson Immunoresearch Laboratories. Immunofluorescence im-
ages were taken with either a Zeiss LSM 710 Confocal microscope or an
Olympus IX71 fluorescent microscope.
Crypt Cell Isolation
Crypt cells were isolated as described previously (Sato et al., 2009), with mod-
ifications. A detailed description is provided in the Supplemental Experimental
Procedures. For quantitative PCR (qPCR) experiments, crypt cells were1056 Cell Reports 6, 1046–1058, March 27, 2014 ª2014 The Authorspooled from intestines of two mice. For insulin secretion studies, each crypt
sample was isolated from a single mouse.
Insulin Secretion Assays
Freshly isolated small-intestinal crypts from individual mice were divided
equally between two tubes and washed three times with warm Krebs-Ringer
bicarbonate buffer (KRBB; 115 mmol/l NaCl; 24 mmol/l NaHCO3; 5 mmol/l
KCl; 1 mmol/l MgCl2; 2.5 mmol/l CaCl2; 10 mM HEPES [pH 7.4]) without
glucose and supplemented with 0.25% BSA. The cells were then incubated
with KRBB containing either 3 mM or 15 mM glucose for 20 min at
37C. Supernatant was collected, and insulin was measured by homogenous
time-resolved fluorescence insulin assay using mouse insulin as a standard
(Cisbio). Three independent experiments were performed to analyze insulin
secretion ability in crypt cells.
Transcriptional Analysis
Total RNAs from mouse tissues and crypt cells were purified using TRIzol
reagent (Invitrogen) followed by DNaseI (Promega) digestion. Equal quantities
of DNaseI-treated RNA were reverse transcribed using an iScript cDNA syn-
thesis kit (Bio-Rad). The cDNAs were subjected to conventional PCR method
or real-time qPCR. The qPCR reactions were amplified and analyzed in
triplicate using CFX384 Real-Time PCR detection system (Bio-Rad). All
experiments were repeated twice. Primers and annealing temperatures (Ta)
used for amplification were listed in Supplemental Experimental Procedures
(Table S1). A detailed description of quantitative RT-PCR (qRT-PCR) on
human intestinal organoids was provided in the Supplemental Experimental
Procedures.
Physiological Studies
A single injection of STZ (200 mg per g body weight) was administrated intra-
peritoneally to induce diabetes in 4- to 5-week-old mice. Mice that were not
hyperglycemic (fed BG > 400 mg/dl) 3 days after STZ administration were
excluded from further study. Diabetic animals were fasted overnight (12 hr)
and then given Dox water (0.2 mg/ml doxycycline and 2% sucrose) on day 4
for 3 days. Fasting BG was measured with a One Touch Ultra Glucometer
(LifeScan) after 16–18 hr fast. Fed BG levels weremeasured in the late morning
(10 am–noon) after a 1 hr fast. Glucose tolerance testing was performed after
an overnight fast (16–18 hr), followed by intraperitoneal injection of glucose
(3 g per kg body weight). At the indicated time points, BG was measured
and blood was collected in microvette CB 300 (SARSTEDT) tubes for detec-
tion of serum insulin levels using an Ultrasensitive Mouse Insulin ELISA kit
(Crystal Chem).
Electron Microscopy
Dissected duodenum and pancreas were fixed immediately at 4C overnight
in 2.5% glutaraldehyde and 1% paraformaldehyde. Samples were rinsed
with 0.1 M sodium cacodylate, postfixed with 1% osmium tetoxide, dehy-
drated with ethanol, and embedded in Epon resin. Semithin sections
(1 mm) stained with toloudine blue were used to identify neoislet structures
in the DTG duodenum by comparing with wild-type duodenum. Regular ultra-
thin sections were prepared for electron microscopic examination of gran-
ules. Digital images were acquired with a JEOL-1010 transmission electron
microscope.
Human Intestinal Organoid Culture
Human ESC-derived intestinal organoids (HIOs) were generated and main-
tained as previously described (McCracken et al., 2011; Spence et al.,
2011), with some modifications. A detailed description of HIOs and inducible
HIO culture is provided in the Supplemental Experimental Procedures. Briefly,
HIOs were infected with virus twice and then harvested 15 days after infection
for IF and qRT-PCR analysis. Inducible HIOs were treated with 2 mg/ml of
doxycycline for 10 days then collected for IF and RNA analysis. Each HIOs
experiment included at least three independent biological replicates, and
each biological replicate consisted of a pool of 3–5 organoids. All work
involving human pluripotent (embryonic) stem cells was reviewed and
approved by the University of Michigan Human Pluripotent Stem Cell
Research Oversight committee.
Statistical Analysis
p values were calculated by Student’s t test. One-way ANOVA analysis was
used in the insulin secretion assay to compare multiple groups. Error bars
reflect SEM or SD as described in each individual figure legend.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and two tables and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2014.02.013.
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